Search

everythinglearnresearchcommunity

for

Search:↓

A woman with advanced eye cancer went into complete remission using a combination of immunotherapy and topical treatments.

Tofacitinib helped a woman regrow hair with no major side effects.

Higher monocyte counts may predict poor response to adalimumab in hidradenitis suppurativa patients.

A parasite-derived molecule speeds up skin healing and affects immune cell behavior without increasing scarring.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Infliximab can cause SAPHO syndrome, which may improve with Spesolimab and methotrexate.

Dupilumab helps children with alopecia areata regrow hair safely.

Ocrelizumab may cause pancreatitis in some patients.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

Tislelizumab can cause cutaneous lupus erythematosus.

Biosimilars lower costs but don't significantly improve access.

Both treatments for alopecia areata are equally effective and safe.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Emulgels are effective for delivering skin medications and cosmetics due to their easy application and controlled release.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Hibiscus mucilage is an effective gelling agent for diclofenac diethylamine gel.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.

MTX and GC combinations are the most effective for early rheumatoid arthritis.

Semaglutide does not significantly increase the risk of hair loss.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Lack of TG2 increases fat storage and lowers cell cleanup in skin oil cells.

The combination therapy is safe and more effective for treating pediatric facial and cervical vitiligo.

Alopecia universalis from alemtuzumab in multiple sclerosis can be reversed with specific treatments.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.

Tofacitinib may be an effective and safe treatment for adolescent alopecia areata.

Dupilumab may help treat alopecia areata without needing high IgE levels.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.